Top 10 Key Players companies in Voglibose by Highest Patent Value in the South Korea in 2022 – Discovery

Free Trial

The Voglibose top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Voglibose Key Players in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company. Voglibose was first launched in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus.

Ranking Year:

Region:

Ranking:

1	CJ CheilJedang Corp.	South Korea	Sugar,Food processing,Food industry, ...[+2]	Avg patent value: 64,000
2	HK inno.N Corp.	South Korea	Drug development,Drug discovery,Gastrointestinal agent, ...[+2]	Avg patent value: 64,000
3	FNG Research Co., Ltd.	South Korea		Avg patent value: 30,000
4	Amorepacific Corp.	South Korea	Cosmetics,Cleanser,Toothpaste, ...[+2]	Avg patent value: 27,000
5	Kolon Industries, Inc.	South Korea	Yarn,Aramid,Fiber, ...[+2]	Avg patent value: 0
6	Hanmi Pharmaceutical Co., Ltd.	South Korea	Medicine,Health care,Drug development, ...[+2]	Avg patent value: 0
7	Yuhan Corp.	South Korea	Drug,Health care,Over-the-counter, ...[+2]	Avg patent value: 0
8	DAE HWA PHARM Co., Ltd.	South Korea	Medicine,Drug,Anti-inflammatory, ...[+2]	Avg patent value: 0
9	KOLON LIFE SCIENCE, Inc.	South Korea	Medicine,Gene,Water treatment, ...[+2]	Avg patent value: 0
10	Hanmi Science Co., Ltd.	South Korea	Clinical trial,Medicine,Drug repositioning, ...[+2]	Avg patent value: 0